International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.
The National Institute for Health and Care Excellence (NICE) has approved a drug combination of dabrafenib with trametinib for treating patients who have previously been affected by skin cancer, melanoma.
A study published by the Journal of Investigative Dermatology has revealed promising results for a new vaccine that could prevent acne vulgaris.
Skincare and supplement company ZENii has added two new vegan skin-focused supplements to its professional range.
The Food and Drug Administration (FDA) has cleared the CustomFlex Artificial in the US, a prosthetic iris that is surgically implanted to treat adults and children whose iris is damaged or missing due to aniridia (a congenital condition) or other damages to the area.
Practitioners were invited to attend an exclusive early morning breakfast workshop at the Royal Society of Medicine in London on Friday February 23 to learn about the new Calecim Professional products.
Skincare developer AlumierMD has chosen aesthetic practitioner and founder of Perfect Skin Solutions, Dr Dev Patel, as its 2018 key opinion leader.
Skincare company NeoStrata has added the Skin Active Tri-Therapy Lifting Serum to its product portfolio.
Global pharmaceutical company Allergan has announced that Botox Cosmetic (onabotulinumtoxinA) has been approved by the US Food and Drug Administration for its third indication.
Aesthetic supplement manufacturer MINERVA Research Labs has announced 'positive results' for its latest clinical trial on GOLD COLLAGEN FORTE.